THE LEONARD & MADLYN ABRAMSON FAMILY CANCER RESEARCH INSTITUTE

THE LEONARD & MADLYN ABRAMSON FAMILY CANCER RESEARCH INSTITUTE

Philadelphia, PA, US
501(c)3
EIN
23-2929823

THE LEONARD & MADLYN ABRAMSON FAMILY CANCER RESEARCH INSTITUTE

Philadelphia, PA, US
501(c)3
EIN
23-2929823

Balance Sheet

Fiscal Year Start:
Jul 1
Assets in 2024 (Year End)

$13,885,541

Cash & Equivalents
>99%
Receivables (Non-Related)
<1%
Related-Party Receivables
0%
Inventories
0%
Prepaid Expenses
0%
Investments
0%
Property, Plant, & Equipment (net)
0%
Other Assets
0%
Liabilities in 2024 (Year End)

$331,012

Other Liabilities
82%
Deferred Revenue
18%
Payables & Accruals
0%
Grants Payable
0%
Tax-Exempt Bond Liabilities
0%
Custodial & Escrow Liabilities
0%
Notes Payable / Debt (Non-Related)
0%
Related-Party Payables
0%
Assets
2023
2024
Change
Cash & Equivalents
$13,775,633
$13,877,541
+1%
Receivables (Non-Related)
$7,500
$8,000
+7%
Related-Party Receivables
-
-
-
Inventories
-
-
-
Prepaid Expenses
$10,000
-
-
Investments
$700,000
-
-
Property, Plant, & Equipment (net)
$0
$0
-
Other Assets
-
-
-
Total Assets
$14,493,133
$13,885,541
-4%
Liabilities
2023
2024
Change
Payables & Accruals
$0
-
-
Grants Payable
-
-
-
Deferred Revenue
$38,600
$58,400
+51%
Tax-Exempt Bond Liabilities
-
-
-
Custodial & Escrow Liabilities
-
-
-
Notes Payable / Debt (Non-Related)
-
-
-
Related-Party Payables
-
-
-
Other Liabilities
$2,256,896
$272,612
-88%
Total Liabilities
$2,295,496
$331,012
-86%
Net assets
2023
2024
Change
Restricted Net Assets
$1,017,890
$1,155,208
+13%
Unrestricted Net Assets
$11,179,747
$12,399,321
+11%
Net assets
2023
2024
Change
Net assets
+$12,197,637
+$13,554,529
+11%
Balance Sheet
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)